REG - Revolution Beauty Gp - Termination of Formal Sale Process

Revolution BeautyAnnouncement

Yesterday 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250822:nRSV3428Wa&default-theme=true

RNS Number : 3428W  Revolution Beauty Group PLC  22 August 2025

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF
THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW
BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("MAR"), AND IS
DISCLOSED IN ACCORDANCE WITH THE COMPANY'S OBLIGATIONS UNDER ARTICLE 17 OF
MAR.

FOR IMMEDIATE RELEASE

22 August 2025

Revolution Beauty Group Plc

("Revolution Beauty" or the "Company")

TERMINATION OF FORMAL SALE PROCESS

The Company announced on 21 May 2025 that the Board had decided to commence a
"Formal Sale Process" for the Company (as referred to in Note 2 on Rule 2.6 of
the City Code on Takeovers and Mergers) (the "Formal Sale Process").

Since that announcement, the Board has concluded that it has not received a
proposal that would lead to an offer for the Company which would be
recommendable by the Board, and the Board does not believe that continuing or
expanding the Formal Sale Process will deliver an outcome that would
satisfactorily meet the interests of all stakeholders. The Board therefore
considers that it is in the interests of all shareholders to now terminate the
Formal Sale Process. The Company has terminated discussions with all parties
in relation to the Formal Sale Process and is not in receipt of any
approaches.

As previously announced, the Company has continued to advance its engagement
with its shareholders, including in respect of a potential equity raise, and
the Board intends to announce a fundraise, including a placing via accelerated
bookbuild, later today. A further announcement will follow shortly.

As a result of this announcement, the Company is no longer in an "Offer
Period" as defined in the City Code on Takeovers and Mergers (the "Takeover
Code") and, accordingly, the dealing disclosure requirements under Rule 8 of
the Takeover Code no longer apply.

For further information, please contact:

 Revolution Beauty Group Plc
 Iain McDonald (Non-executive Chair) / Neil Catto (CFO)                              +44 (0)20 3805 4822 (Via Headland Consultancy)

 Panmure Liberum Limited (Sole Financial Adviser, NOMAD and Joint Broker, Sole       +44 (0)20 3100 2222
 Rule 3 Adviser)
 Investment Banking: Bidhi Bhoma / Dru Danford / Edward Thomas / John More

 M&A: Tim Medak

 Zeus Capital                                                                        +44 (0)161 831 1512
 Ben Robertson / Dominic King / Jordan Warburton

 Headland Consultancy (Public Relations)                                             +44 (0)20 3805 4885
 Matt Denham / Antonia Pollock

 

The person responsible for arranging this announcement on behalf of the
Company is Neil Catto, Chief Financial Officer.

Notice related to financial advisers

Panmure Liberum Limited ("Panmure Liberum"), which is authorised and regulated
by the Financial Conduct Authority in the United Kingdom, is acting
exclusively for Revolution Beauty and for no one else in connection with the
subject matter of this announcement and will not be responsible to anyone
other than Revolution Beauty for providing the protections afforded to its
clients or for providing advice in connection with the subject matter of this
announcement.

Zeus Capital Limited, which is authorised and regulated by the Financial
Conduct Authority in the United Kingdom, is acting exclusively for Revolution
Beauty and for no one else in connection with the subject matter of this
announcement and will not be responsible to anyone other than Revolution
Beauty for providing the protections afforded to its clients or for providing
advice in connection with the subject matter of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCFFFFLTRILFIE